Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
The DOI matches its Crossref record, with a small difference in title or year; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel–Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability. pVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent. The 1.85 angstrom structure of a 20-residue HIF-1α peptide–pVHL–ElonginB–ElonginC complex shows that HIF-1α binds to pVHL in an extended β strand–like conformation. The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues. Although the β sheet–like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic of signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The subsequent discovery of a peptide from hypoxia-inducible factor 1 subunit-α (HIF1α) that bound the E3 ligase von Hippel–Lindau tumour suppressor (VHL)18,19 led to the design of cell-penetrating PROTACs that degraded a range of POIs.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [19]
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Self-citationA conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Self-citationSCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Structural Basis of Collagen Recognition by Integrin α2β1
Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. J., & Liddington, R. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80622-4 · Cited by 1,005
Research works printed but not linked: 2
- A. Pause et al. Proc. Natl. Acad. Sci. U.S.A. 94 2156 (1997).
- We thank P. Jeffrey for help with data collection and processing C. E. Stebbins and the members of the Pavletich lab for helpful discussions C. Murray and M. Minto for administrative assistance J. Crawford for peptide synthesis and the staff of the Cornell High Energy Synchrotron Source for help with data collection. This work was supported by the NIH the Howard Hughes Medical Institute the Dewitt Wallace Foundation the Samuel and May Rudin Foundation and the Arthur and Rochelle Belfer Foundation. Coordinates have been deposited in the RCSB Protein Data Bank (accession code 1LM8). Supporting Online Material www.sciencemag.org/cgi/content/full/1073440/DC1 Materials and Methods SFigs. 1 to S4
Cited by
Items 301–400 of 865
Hypoxia in aquatic invertebrates: Occurrence and phenotypic and molecular responses
Lee, Y., Byeon, E., Kim, D., Maszczyk, P., Wang, M., Wu, R. S. S., Jeung, H.-D., Hwang, U.-K., & Lee, J. (2023) · Aquatic Toxicology · doi:10.1016/j.aquatox.2023.106685 · Cited by 54
Scanning Protein Surfaces with DNA‐Encoded Libraries
Kunig, V. B. K., Potowski, M., Škopić, M. K., & Brunschweiger, A. (2020) · ChemMedChem · doi:10.1002/cmdc.202000869 · Cited by 54
Protein degradation and iron homeostasis
Thompson, J. W., & Bruick, R. K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.02.003 · Cited by 55
Roles of F-box Proteins in Plant Hormone Responses
Yu, H., Wu, J., Xu, N., & Peng, M. (2007) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2007.00358.x · Cited by 54
Choi, K.-O., Lee, T., Lee, N., Kim, J., Yang, E. G., Yoon, J. M., Kim, J. H., Lee, T. G., & Park, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015271 · Cited by 53
ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling
Wu, Q., Zhou, X., Li, P., Ding, M., You, S., Xu, Z., Ye, J., Chen, X., Tan, M., Wang, J., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01935-5 · Cited by 53
Twists and turns in ubiquitin‐like protein conjugation cascades
Schulman, B. A. (2011) · Protein Science · doi:10.1002/pro.750 · Cited by 53
Liu, S., Wang, J., Peng, S., Li, T., Ning, X., Hong, B., Liu, J., Wu, P., Zhou, B., Zhou, J., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.261 · Cited by 53
SM-20, EGL-9, and the EGLN Family of Hypoxia-inducible Factor Prolyl Hydroxylases
Freeman, R. S., Hasbani, D. M., Lipscomb, E. A., Straub, J. A., & Xie, L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13758-7 · Cited by 52
Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
Wang, H., Zhou, R., Xu, F., Yang, K., Zheng, L., Zhao, P., Shi, G., Dai, L., Xu, C., Yu, L., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00385-8 · Cited by 51
Ling, T. S., Shi, R. H., ZHANG, G. X., Zhu, H. Y., Yu, L. Z., & Ding, X. (2005) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2005.00223.x · Cited by 51
Solution Structure of the Human Ubiquitin-specific Protease 15 DUSP Domain
de Jong, R. N., Eiso, A. B., Diercks, T., Truffault, V., Daniëls, M., Kaptein, R., & Folkers, G. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510993200 · Cited by 51
Al-Sheikh, M., Moradkhani, K., Lopez, M., Wajcman, H., & Préhu, C. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.07.017 · Cited by 50
Ma, Z., Jin, X., Qian, Z., Li, F., Xu, M., Zhang, Y., Kang, X., Li, H., Gao, X. Y., Zhao, L., et al. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1620572 · Cited by 50
Hasanov, E., & Jonasch, E. W. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1925248 · Cited by 50
Hipoxia tumoral. Papel del factor inducible por hipoxia
Fraga, A. M., Ribeiro, R. J. T., & Medeiros, R. (2009) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(09)72891-8 · Cited by 50
Lee, H., Lee, T., Lee, N., Yang, E. G., Lee, C., Lee, J., Moon, E., Ha, J., & Park, H. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr034 · Cited by 50
Liu, F., Zhang, W., You, X., Liu, Y., Li, Y., Wang, Z., Wang, Y., Zhang, X., & Ye, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4508 · Cited by 49
Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF
Wheeler, J. A., & Clinkenbeard, E. L. (2019) · Current Molecular Biology Reports · doi:10.1007/s40610-019-0110-9 · Cited by 49
Straub, J. A., Lipscomb, E. A., Yoshida, E. S., & Freeman, R. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01688.x · Cited by 38
Transcriptional Regulation of Serine/Threonine Kinase-15 (STK15) Expression by Hypoxia and HIF-1
Klein, A. M., Flügel, D., & Kietzmann, T. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-01-0042 · Cited by 49
Role of Carcinoma-Associated Fibroblasts and Hypoxia in Tumor Progression
Giaccia, A. J., & Schipani, E. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_73 · Cited by 48
Zhang, Y., Gu, W., Chen, W., Zhu, J., Fan, L., Zhang, L., Zhao, L., & Miao, Q. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c18398 · Cited by 48
Lucas, X., Van Molle, I., & Ciulli, A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00842 · Cited by 42
HIF-2α-pVHL complex reveals broad genotype-phenotype correlations in HIF-2α-driven disease
Tarade, D., Robinson, C. M., Lee, J. E., & Ohh, M. (2018) · Nature Communications · doi:10.1038/s41467-018-05554-1 · Cited by 48
Small-Molecule Approaches to Targeted Protein Degradation
Faust, T. B., Donovan, K. A., Yue, H., Chamberlain, P. P., & Fischer, E. S. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-051420-114114 · Cited by 44
Katschinski, D. M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01952.x · Cited by 46
The Genetic Basis of Pheochromocytoma and Paraganglioma: Implications for Management
Shuch, B. M., Ricketts, C. J., Metwalli, A. R., Pacák, K., & Linehan, W. M. (2014) · Urology · doi:10.1016/j.urology.2014.01.007 · Cited by 47
Hypoxic preconditioning protects against ischemic brain injury
Sharp, F. R., Ran, R., Lu, A., Tang, Y., Strauss, K. I., Glass, T. F., Ardizzone, T. D., & Bernaudin, M. (2004) · Neurotherapeutics · doi:10.1007/bf03206565 · Cited by 45
Genetic causes of erythrocytosis and the oxygen-sensing pathway
Lee, F. S. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.04.003 · Cited by 47
VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo
Lee, C. M., Hickey, M. M., Sanford, C. A., McGuire, C., Cowey, C. L., Simon, M. C., & Rathmell, W. K. (2009) · Oncogene · doi:10.1038/onc.2009.12 · Cited by 46
Delivery of miR-155 to retinal pigment epithelial cells mediated by Burkitt’s lymphoma exosomes
Yoon, C., Kim, J., Park, G., Kim, S., Kim, D., Hur, D. Y., Kim, B., & Kim, Y. S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3769-4 · Cited by 46
The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis
Hudler, P., & Urbančič, M. (2022) · Genes · doi:10.3390/genes13020362 · Cited by 47
Zhang, W., Li, G., Deng, L., Qiu, S., & Deng, R. (2012) · Journal of Orthopaedic Science · doi:10.1007/s00776-012-0206-z · Cited by 46
Saito, Y., Sunamura, M., Motoi, F., Abe, H., Egawa, S., Duda, D. G., Hoshida, T., Fukuyama, S., Hamada, H., & Matsuno, S. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700902 · Cited by 46
WEST, C., Wel, H. V. D., Sassi, S., & Gaucher, E. A. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.04.007 · Cited by 46
Guo, K., Wei, Y., Wang, Z., Zhang, X., Zhang, X., Liu, X., Wu, W., Wu, Z., Zhang, L., & Cui, C. (2022) · Cell Death and Disease · doi:10.1038/s41419-021-04135-3 · Cited by 45
Setia, N., Almuqdadi, H. T. A., & Abid, M. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116041 · Cited by 45
Proline Analogues in Drug Design: Current Trends and Future Prospects
Kubyshkin, V., & Mykhailiuk, P. K. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01987 · Cited by 45
Drug Discovery Approaches to Target E3 Ligases
Rodríguez-Gimeno, A., & Galdeano, C. (2024) · ChemBioChem · doi:10.1002/cbic.202400656 · Cited by 45
Mamalis, A. A., & Cochran, D. L. (2011) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2011.05.001 · Cited by 45
Molecular markers of paragangliomas/pheochromocytomas
Zhikrivetskaya, S. O., Snezhkina, A. V., Zaretsky, A. R., Alekseev, B. Y., Pokrovsky, A. V., Golovyuk, A. L., Melnikova, N. V., Stepanov, O. A., Kalinin, D. V., Moskalev, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15201 · Cited by 45
Li, C., Xiong, W., Liu, X., Xiao, W., Guo, Y., Tan, J., & Li, Y. (2019) · Oncogenesis · doi:10.1038/s41389-019-0135-1 · Cited by 35
Couvé, S., Ladroue, C., Laine, É., Mahtouk, K., Guégan, J., Gad, S., Jeune, H. L., Gentil, M. L., Nuel, G., Kim, W. Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1161 · Cited by 45
Self-citationSelective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs
Chang, M., Gao, F., Gnawali, G. R., Xu, H., Dong, Y., Meng, X., Li, W., Wang, Z., Lopez, B., Carew, J. S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00152 · Cited by 44
Von Hippel-Lindau Disease and the Eye
Karimi, S., Arabi, A., Shahraki, T., & Safi, S. (2020) · Journal of Ophthalmic and Vision Research · doi:10.18502/jovr.v15i1.5950 · Cited by 44
Zhu, L., Ding, R., Yan, H., Zhang, J., & Lin, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2541-x · Cited by 44
Murray, J. K., Chenera, B., Allgeier, A. M., Kasparian, A. J., Viswanadhan, V. N., Wilde, C., Allen, J. R., Yoder, S. C., Biddlecome, G. H., Hungate, R. W., et al. (2010) · Journal of Combinatorial Chemistry · doi:10.1021/cc100073a · Cited by 44
The von Hippel-Lindau Tumor Suppressor Protein Is a Molten Globule under Native Conditions
Sutovsky, H., & Gazit, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311225200 · Cited by 44
Leu-574 of HIF-1α Is Essential for the von Hippel-Lindau (VHL)-mediated Degradation Pathway
Huang, L. E., Pete, E. A., Schau, M., Milligan, J., & Gu, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207280200 · Cited by 37
Semenza, G. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192442299 · Cited by 44
He, W., Batty-Stuart, S., Lee, J. E., & Ohh, M. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167244 · Cited by 43
Belzutifan: a novel therapeutic for the management of von Hippel–Lindau disease and beyond
Curry, L. C., & Soleimani, M. (2024) · Future Oncology · doi:10.2217/fon-2023-0679 · Cited by 43
Torales‐Cardeña, A., Martínez-Torres, I., Rodríguez–Martínez, S., Gómez‐Chávez, F., Cancino‐Díaz, J. C., Vázquez-Sánchez, E. A., & Cancino-Diaz, M. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/607363 · Cited by 218
Dimova, E., Michiels, C., & Kietzmann, T. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649358 · Cited by 37
Minchenko, O. H., Opentanova, I. L., Ogura, T., Minchenko, D. O., Комісаренко, С. В., Caro, J., & Esumi, H. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3402 · Cited by 42
Oehme, F., Jonghaus, W., Narouz-Ott, L., Hütter, J. F., & Flamme, I. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.066 · Cited by 40
Salvaris, R., Brennan, J., & Lewis, K. L. (2025) · Cancers · doi:10.3390/cancers17030557 · Cited by 41
Dey, P., Velázquez‐Villegas, L. A., Faria, M., Turner, A. P. F., Jonsson, P., Webb, P., Williams, C., Gustafsson, J.-Å., & Ström, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128239 · Cited by 41
Maneiro, M., Vita, E. D., Conole, D., Kounde, C. S., Zhang, Q., & Tate, E. W. (2021) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2021.01.002 · Cited by 41
VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
Ganner, A., Gehrke, C., Klein, M., Thegtmeier, L., Matulenski, T., Wingendorf, L., Wang, L., Pilz, F., Greidl, L., Meid, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94132-5 · Cited by 41
Liu, J., & Nussinov, R. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.022 · Cited by 37
Stewart, A. J., Houston, B., & Farquharson, C. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20481 · Cited by 41
What influences the activity of Degrader−Antibody conjugates (DACs)
Guo, Y., Li, X., Xie, Y., & Wang, D. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116216 · Cited by 40
Regulation of Bone Marrow Angiogenesis by Osteoblasts during Bone Development and Homeostasis
Schipani, E., Wu, C., Rankin, E. B., & Giaccia, A. J. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00085 · Cited by 40
Kuo, W., Shih, C., Lin, C., Cheng, W.-E., Chen, S., Chen, W., & Lee, Y.-L. (2011) · Translational research · doi:10.1016/j.trsl.2011.09.003 · Cited by 40
The pan-cancer pathological regulatory landscape
Falco, M. M., Bleda, M., Carbonell‐Caballero, J., & Dopazo, J. (2016) · Scientific Reports · doi:10.1038/srep39709 · Cited by 40
Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
Burslem, G. M., Kyle, H. F., Nelson, A., Edwards, T. A., & Wilson, A. J. (2017) · Chemical Science · doi:10.1039/c7sc00388a · Cited by 39
U19/Eaf2 Binds to and Stabilizes von Hippel-Lindau Protein
Xiao, W., Ai, J., Habermacher, G. M., Volpert, O. V., Yang, X. J., Zhang, A.-Y., Hahn, J., Cai, X., & Wang, Z. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2595 · Cited by 39
Lu, Z. H., Wright, J. D., Belt, B. A., Cardiff, R. D., & Arbeit, J. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061138 · Cited by 39
Feeding the machine: mechanisms of proteasome-catalyzed degradation of ubiquitinated proteins
Crews, C. M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.08.002 · Cited by 39
Erythrocytosis associated with a novel missense mutation in the HIF2A gene
van Wijk, R., Sutherland, S., Van Wesel, A. C. W., Huizinga, E. G., Percy, M. J., Bierings, M., & Lee, F. S. (2010) · Haematologica · doi:10.3324/haematol.2009.017582 · Cited by 38
Shi, L., Yan, Y., He, Y., Yan, B., Pan, Y., Orme, J. J., Zhang, J., Xu, W., Pang, J., & Huang, H. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3258 · Cited by 38
Two new mutations in the HIF2A gene associated with erythrocytosis
Percy, M. J., Chung, Y. J., Harrison, C., Mercieca, J., Hoffbrand, A. V., Dinardo, C. L., Santos, P. C. J. L., Fonseca, G. H. H., Gualandro, S. F. M., Pereira, A. C., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23123 · Cited by 37
Perier, A., Fregni, G., Wittnebel, S., Gad, S., Allard, M., Gervois, N., Escudier, B. J., Azzarone, B. G., & Caignard, A. (2011) · Oncogene · doi:10.1038/onc.2010.638 · Cited by 37
A Synthetic Oxygen Sensor for Plants Based on Animal Hypoxia Signaling
Iacopino, S., Jurinovich, S., Cupellini, L., Piccinini, L., Cardarelli, F., Pierdomenico Perata, A., Mennucci, B., Giuntoli, B., & Licausi, F. (2018) · PLANT PHYSIOLOGY · doi:10.1104/pp.18.01003 · Cited by 37
Hypoxia-Inducible Factors: Post-translational Crosstalk of Signaling Pathways
Dimova, E. Y., & Kietzmann, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_13 · Cited by 37
Protein degraders - from thalidomide to new PROTACs
Ito, T. (2023) · The Journal of Biochemistry · doi:10.1093/jb/mvad113 · Cited by 36
UPLC–MS-Based Procedures to Detect Prolyl-Hydroxylase Inhibitors of HIF in Urine
Mazzarino, M., Perretti, I., Stacchini, C., Comunità, F., de la Torre, X., & Botrè, F. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa055 · Cited by 36
Daam2 driven degradation of VHL promotes gliomagenesis
Zhu, W., Krishna, S., Garcia, C., Lin, C.-C. J., Mitchell, B. D., Scott, K. L., Mohila, C., Creighton, C. J., Yoo, S. H., Lee, H. K., et al. (2017) · eLife · doi:10.7554/elife.31926 · Cited by 36
Santana‐Blank, L. A., Rodríguez–Santana, E., & Santana‐Rodríguez, K. E. (2005) · Photomedicine and Laser Surgery · doi:10.1089/pho.2005.23.416 · Cited by 36
Identification of Protein-Protein Interactions with Glutathione-S-Transferase (GST) Fusion ProteinsPreprint
Einarson, M. B., Pugacheva, E. N., & Orlinick, J. R. (2007) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top11 · Cited by 36
Tandem‐Activatable PROTAC Prodrug for Tumor Biomarker‐Driven Near‐Infrared Opto‐Proteolysis
Lu, X., Wang, X., Liao, H., Sha, B., Zhang, Y., & Li, J. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202510641 · Cited by 35
Biochemistry of the hypoxia-inducible factor hydroxylases
Fiorini, G., & Schofield, C. J. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102428 · Cited by 35
Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma
Ashouri, K. B., Mohseni, S., Tourtelot, J. B., Sharma, P., & Spiess, P. E. (2015) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.2015.41 · Cited by 35
Knauth, K., Cartwright, E. J. P., Freund, S. M. V., Bycroft, M., & Buchberger, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809056200 · Cited by 35
Nicholas, S. A., & Sumbayev, V. V. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.76 · Cited by 35
Phosphorylation of von Hippel-Lindau protein by checkpoint kinase 2 regulates p53 transactivation
Roe, J., Kim, H.-R., Hwang, I., Ha, N., Kim, S., Cho, E., & Youn, H. (2011) · Cell Cycle · doi:10.4161/cc.10.22.18096 · Cited by 35
Melatonin Suppresses Hypoxia-Induced Migration of HUVECs via Inhibition of ERK/Rac1 Activation
Ling, Y., Zheng, J., Xu, R., Zhang, Y., Gu, L., Dong, J., Zhu, Y., Zhou, R., Zheng, L., Zhang, X., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150814102 · Cited by 35
Genetically heterogeneous origins of idiopathic erythrocytosis
Percy, M. J. (2007) · Hematology · doi:10.1080/10245330601111979 · Cited by 35
Protein kinase C‐δ regulates the stability of hypoxia‐inducible factor‐1α under hypoxia
Lee, J., Park, J. A., Kim, S., Seo, J. H., Lim, K., Jeong, J., Jeong, C., Chun, K., Lee, S., Kwon, Y., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00535.x · Cited by 35
Xue, X., Zhao, N.-Y., Yu, H., Sun, Y., Chen, K., Huang, Q.-B., Sun, H.-P., Wang, X., & Li, N. (2016) · PeerJ · doi:10.7717/peerj.2757 · Cited by 34
Saravia, J., Paschke, K., Oyarzún, R., Cheng, C.-H. C., Navarro, J. M., & Vargas‐Chacoff, L. (2021) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2021.103021 · Cited by 34
Elevated glucose increases genomic instability by inhibiting nucleotide excision repair
Ciminera, A. K., Shuck, S. C., & Termini, J. S. (2021) · Life Science Alliance · doi:10.26508/lsa.202101159 · Cited by 34
Internal En Bloc Resection and Genetic Analysis of Retinal Capillary Hemangioblastoma
Schlesinger, T. K., Appukuttan, B., Hwang, T., Atchaneeyakasul, L.-O., Chan, C.-C., Zhuang, Z., Stout, J. T., & Wilson, D. J. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.9.1189 · Cited by 34
The CRL2LRR-1 ubiquitin ligase regulates cell cycle progression during C. elegans development
Merlet, J., Burger, J., Tavernier, N., Richaudeau, B., Gomes, J., & Pintard, L. (2010) · Development · doi:10.1242/dev.054866 · Cited by 34
Ruiz‐Llorente, S., Bravo, J., Cebrián, A., Cascón, A., Pollán, M., Tellería, D., Letón, R., Urioste, M., Rodríguez‐López, R., de Campos, J. M., et al. (2004) · Human Mutation · doi:10.1002/humu.10309 · Cited by 34
Nan, Y., Wu, X., Luo, Q., Chang, W., Zhao, P., Zhang, L., & Liu, Z. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315348121 · Cited by 33
Perrotta, S., Stiehl, D. P., Punzo, F., Scianguetta, S., Borriello, A., Bencivenga, D., Casale, M., Nobili, B., Fasoli, S., Balduzzi, A., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.088369 · Cited by 33
Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome
Dmitrieva, N. I., Walts, A. D., Nguyen, D. P., Grubb, A. F., Zhang, X., Wang, X., Ping, X., Jin, H. Z., Yu, Z., Yu, Z., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135490 · Cited by 33
Metadata
- Authors
- Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Dana-Farber Cancer Institute (US)
- Massachusetts Institute of Technology (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Science
- Published
- 2002-06-07
- Volume
- 296
- Issue
- 5574
- Pages
- 1886-1889
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2596045242
- Cited by
- 765
- References
- 25
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 37 · 2023: 44 · 2022: 33 · 2021: 32 · 2020: 39 · 2019: 27 · 2018: 24 · 2017: 26 · 2016: 27 · 2015: 30 · 2014: 28 · 2013: 28 · 2012: 24
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIF-1α, VHL, hydroxylation, protein-protein complex structure, hypoxia signaling, tumor suppressor mutations, beta-strand conformation, oxygen sensing
- MeSH terms
- Elongin, Amino Acid Sequence, Animals, Binding Sites, Humans, Hydrogen Bonding, Hydroxylation, Hydroxyproline, Ligases, Models, Molecular, Molecular Sequence Data, Mutation, Protein Conformation, Transcription Factors, Signal Transduction, Protein Structure, Secondary, Protein Structure, Tertiary, Crystallography, X-Ray, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Macromolecular Substances, Mice, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.